| Dr Joe Lam, PHARM D | |
|
1600 Eureka Rd, Roseville, CA 95661-3027 | |
| (916) 784-5471 | |
| (916) 784-5434 |
| Full Name | Dr Joe Lam |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1600 Eureka Rd, Roseville, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578645982 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 54028 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joe Lam, PHARM D 1600 Eureka Rd, Roseville, CA 95661-3027 Ph: () - | Dr Joe Lam, PHARM D 1600 Eureka Rd, Roseville, CA 95661-3027 Ph: (916) 784-5471 |
News Archive
Results revealed today at The International Liver Congress 2015 show that vitamin E (d-alpha-tocopherol) is an effective treatment for non-alcoholic steatohepatitis (NASH). NASH occurs when the liver becomes inflamed due to the accumulation of fat. Over time, persistent inflammation can lead to the formation of fibrous scar tissue in the liver and around its blood vessels, which can eventually cause cirrhosis.
CompPharma, a consortium of workers' compensation pharmacy benefit managers, has compiled a directory of terms and definitions describing various aspects of the workers' compensation pharmacy industry.
Exelixis, Inc. today announced the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA) for COMETRIQ (cabozantinib) for the proposed indication of treatment of progressive, unresectable, locally advanced, or metastatic medullary thyroid cancer (MTC).
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of brain and other cancers, today announced that it will be presenting today, at the Annual Meeting of the Congress of Neurological Surgeons in New Orleans, Louisiana at 3:15pm central time, data from its Phase I clinical trial investigating the role that its ICT-107 vaccine may play in increasing patient survival and inhibiting tumor progression in patients with glioblastoma, the most common and most aggressive type of primary brain tumor.
› Verified 5 days ago
Lynn Tuyet Nguyen, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1600 Eureka Rd, Roseville, CA 95661 Phone: 916-784-4000 | |
Carol Lynn Schulz, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1600 Eureka Rd, Roseville, CA 95661 Phone: 916-784-4184 | |
Jessica Ng, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1600 Eureka Rd, Roseville, CA 95661 Phone: 916-474-6555 | |
Dr. Mina Eskandar, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1298 Antelope Creek Dr, #521, Roseville, CA 95678 Phone: 518-506-2513 | |
Madison Le, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9280 Sierra College Blvd, Roseville, CA 95661 Phone: 916-772-5313 | |
Mr. Joseph Chadwick Jacobs, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 446 Roseville Sq, Roseville, CA 95678 Phone: 916-784-1590 Fax: 916-784-1728 | |
Saimah Arshad, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 Riverside Ave, Roseville, CA 95678 Phone: 916-486-5256 |